Compare with FORTIS HEALTHCARE - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

KRSNAA DIAGNOSTICS vs FORTIS HEALTHCARE - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    KRSNAA DIAGNOSTICS FORTIS HEALTHCARE KRSNAA DIAGNOSTICS/
FORTIS HEALTHCARE
 
P/E (TTM) x - 24.5 - View Chart
P/BV x 7.3 2.9 250.1% View Chart
Dividend Yield % 0.0 0.0 -  

Financials

 KRSNAA DIAGNOSTICS   FORTIS HEALTHCARE
EQUITY SHARE DATA
    KRSNAA DIAGNOSTICS
Mar-21
FORTIS HEALTHCARE
Mar-21
KRSNAA DIAGNOSTICS/
FORTIS HEALTHCARE
5-Yr Chart
Click to enlarge
High RsNA217 0.0%   
Low RsNA113 0.0%   
Sales per share (Unadj.) Rs998.853.4 1,871.1%  
Earnings per share (Unadj.) Rs284.5-1.4 -20,707.1%  
Cash flow per share (Unadj.) Rs342.12.5 13,820.9%  
Dividends per share (Unadj.) Rs00-  
Avg Dividend yield %00- 
Book value per share (Unadj.) Rs355.581.0 438.6%  
Shares outstanding (eoy) m6.50754.96 0.9%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x03.1 0.0%   
Avg P/E ratio x0-120.0 0.0%  
P/CF ratio (eoy) x066.6 0.0%  
Price / Book Value ratio x02.0 0.0%  
Dividend payout %00-   
Avg Mkt Cap Rs m0124,493 0.0%   
No. of employees `000NANA-   
Total wages/salary Rs m2968,490 3.5%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m6,49240,301 16.1%  
Other income Rs m122466 26.3%   
Total revenues Rs m6,61540,767 16.2%   
Gross profit Rs m3,4664,057 85.4%  
Depreciation Rs m3742,906 12.9%   
Interest Rs m2591,659 15.6%   
Profit before tax Rs m2,955-43 -6,930.6%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,105995 111.1%   
Profit after tax Rs m1,849-1,037 -178.3%  
Gross profit margin %53.410.1 530.4%  
Effective tax rate %37.4-2,333.2 -1.6%   
Net profit margin %28.5-2.6 -1,106.7%  
BALANCE SHEET DATA
Current assets Rs m2,48110,368 23.9%   
Current liabilities Rs m1,83812,330 14.9%   
Net working cap to sales %9.9-4.9 -203.5%  
Current ratio x1.40.8 160.6%  
Inventory Days Days2571 35.0%  
Debtors Days Days41353 11.5%  
Net fixed assets Rs m3,56497,477 3.7%   
Share capital Rs m2,4897,550 33.0%   
"Free" reserves Rs m-17853,629 -0.3%   
Net worth Rs m2,31061,179 3.8%   
Long term debt Rs m1,6809,677 17.4%   
Total assets Rs m6,045107,845 5.6%  
Interest coverage x12.41.0 1,271.7%   
Debt to equity ratio x0.70.2 459.6%  
Sales to assets ratio x1.10.4 287.4%   
Return on assets %34.90.6 6,052.4%  
Return on equity %80.0-1.7 -4,720.8%  
Return on capital %80.52.3 3,531.4%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m021 0.0%   
Fx outflow Rs m011 0.0%   
Net fx Rs m010 0.0%   
CASH FLOW
From Operations Rs m1,0264,855 21.1%  
From Investments Rs m-611-1,351 45.3%  
From Financial Activity Rs m308-1,429 -21.6%  
Net Cashflow Rs m7232,120 34.1%  

Share Holding

Indian Promoters % 27.4 0.0 -  
Foreign collaborators % 0.0 31.2 -  
Indian inst/Mut Fund % 33.1 46.7 70.9%  
FIIs % 4.5 29.8 15.1%  
ADR/GDR % 0.0 0.0 -  
Free float % 72.6 68.8 105.5%  
Shareholders   71,445 156,881 45.5%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare KRSNAA DIAGNOSTICS With:   ASTER DM HEALTHCARE    METROPOLIS HEALTHCARE    DR. LAL PATHLABS    THYROCARE TECHNOLOGIES    MAX HEALTHCARE INSTITUTE    



Today's Market

Indian Share Markets End Marginally Higher; Automobile & Banking Stocks Witness Buying(Closing)

Indian share markets inched higher today tracking Asian peers as they tried to hold onto small gains after weak data from China showed that lockdowns hit the world's second-largest economy.

Related Views on News

Cipla vs Sun Pharma: Which Pharma Stock is Better? (Views On News)

Apr 13, 2022

The pandemic has opened up new opportunities for the Indian pharmaceutical sector. Which company is set to benefit from it?

Nifty Pharma Index - Bulls are Losing the Ground (Views On News)

Mar 16, 2022

For the Nifty pharma index, it seems as if bulls are losing ground as they witness multiple bearish candlestick patterns.

IPO Alert! 3 Companies Including PharmEasy Get the Green Light (Views On News)

Feb 22, 2022

The strong momentum in India's IPO market is poised to continue with the market regulator approving the IPOs of three firms including PharmEasy.

Sun Pharma vs Dr Reddy's: Which is Better? (Views On News)

Dec 16, 2021

In an extremely competitive market, two pharma companies are competing against each other to grab the top spot.

5 Stocks to Watch Out for Amid the Omicron Outbreak (Views On News)

Dec 3, 2021

As the new variant of Covid-19 emerges, keep an eye on these stocks.

More Views on News

Most Popular

2022's Best Performing Penny Stocks So Far...(Views On News)

Mar 2, 2022

We are just two months into 2022 and several penny stocks that we track have already surged 5x.

5 Debt Free Penny Stocks with Good Profitability to Watch Out for in 2022(Views On News)

Mar 16, 2022

Debt free penny stocks are vital when it's a question of portfolio diversification in a volatile market. They can potentially offer good profitability in the long run.

Penny Stocks to Buy and Hold Beyond 2022(Views On News)

Apr 6, 2022

A step-by-step method to pick the best penny stocks for the long term.

6 Penny Stocks that Could Be Hidden Bluechips. Take a Look...(Views On News)

Apr 13, 2022

These penny stocks can become future multibaggers. Watch out for them.

Adani Power vs Tata Power: Which Power Stock is Better?(Views On News)

Feb 28, 2022

Rising electricity consumption provides a lot of scope for growth. Which company has a better chance at capturing it?

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

KRSNAA DIAGNOSTICS SHARE PRICE


May 16, 2022 (Close)

TRACK KRSNAA DIAGNOSTICS

  • Track your investment in KRSNAA DIAGNOSTICS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON KRSNAA DIAGNOSTICS

KRSNAA DIAGNOSTICS 5-YR ANALYSIS

COMPARE KRSNAA DIAGNOSTICS WITH

MARKET STATS